GH Research Plc (GHRS)
27.20
-0.08
(-0.29%)
USD |
NASDAQ |
Sep 11, 16:00
27.16
-0.04
(-0.15%)
After-Hours: 20:00
GH Research Enterprise Value : 1.505B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.505B |
| September 10, 2026 | 1.510B |
| September 09, 2026 | 1.529B |
| September 08, 2026 | 1.545B |
| September 04, 2026 | 1.575B |
| September 03, 2026 | 1.554B |
| September 02, 2026 | 1.564B |
| September 01, 2026 | 1.516B |
| August 31, 2026 | 1.490B |
| August 28, 2026 | 1.556B |
| August 27, 2026 | 1.604B |
| August 26, 2026 | 1.629B |
| August 25, 2026 | 1.623B |
| August 24, 2026 | 1.567B |
| August 21, 2026 | 1.582B |
| August 20, 2026 | 1.606B |
| August 19, 2026 | 1.683B |
| August 18, 2026 | 1.679B |
| August 17, 2026 | 1.696B |
| August 14, 2026 | 1.662B |
| August 13, 2026 | 1.573B |
| August 12, 2026 | 1.713B |
| August 11, 2026 | 1.634B |
| August 10, 2026 | 1.665B |
| August 07, 2026 | 1.716B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.741B |
| August 05, 2026 | 1.637B |
| August 04, 2026 | 1.637B |
| August 03, 2026 | 1.573B |
| July 31, 2026 | 1.564B |
| July 30, 2026 | 1.586B |
| July 29, 2026 | 1.558B |
| July 28, 2026 | 1.557B |
| July 27, 2026 | 1.543B |
| July 24, 2026 | 1.510B |
| July 23, 2026 | 1.534B |
| July 22, 2026 | 1.600B |
| July 21, 2026 | 1.584B |
| July 20, 2026 | 1.527B |
| July 17, 2026 | 1.608B |
| July 16, 2026 | 1.637B |
| July 15, 2026 | 1.486B |
| July 14, 2026 | 1.475B |
| July 13, 2026 | 1.378B |
| July 10, 2026 | 1.457B |
| July 09, 2026 | 1.505B |
| July 08, 2026 | 1.481B |
| July 07, 2026 | 1.484B |
| July 06, 2026 | 1.434B |
| July 02, 2026 | 1.492B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Atai Beckley, Inc. | 2.490B |
| Eli Lilly & Co. | 1.096T |
| Avadel Pharmaceuticals Plc | -- |
| Jazz Pharmaceuticals Plc | 18.14B |
| Perrigo Co. Plc | 4.954B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.15M |
| Total Expenses (Quarterly) | 15.15M |
| EPS Diluted (Quarterly) | -0.2276 |
| Earnings Yield | -3.63% |
| Normalized Earnings Yield | -3.968 |